Edition:
United States

Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

4.09USD
20 Sep 2017
Change (% chg)

-- (--)
Prev Close
$4.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
418,218
52-wk High
$9.19
52-wk Low
$3.15

Chart for

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platform, directed at advancing small molecule compounds that have the... (more)

Overall

Beta: 1.72
Market Cap(Mil.): $559.35
Shares Outstanding(Mil.): 136.76
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 80.38 16.25
EPS (TTM): -- -- --
ROI: -- 2.96 14.87
ROE: -- 4.74 13.89

BRIEF-Achillion announces termination of worldwide collaboration for hepatitis c with Janssen

* Achillion announces termination of worldwide collaboration for hepatitis c with Janssen Further company coverage:

Sep 11 2017

BRIEF-Achillion Pharmaceuticals says Joel Barrish plans to leave co

* Achillion Pharmaceuticals Inc - ‍announced that Joel Barrish, executive vice president and chief scientific officer, plans to leave company

Jul 10 2017

BRIEF-Achillion Q1 loss per share $0.15

* Achillion reports first quarter 2017 financial results and provides update on clinical programs

May 04 2017

BRIEF-Achillion announces initiation of patient dosing in phase 2 study of ACH-4471

* Achillion announces initiation of patient dosing in phase 2 study of ACH-4471 for paroxysmal nocturnal hemoglobinuria

Apr 06 2017

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $35.99 +0.54
Johnson & Johnson (JNJ.N) $133.22 -2.00
Novartis AG (NOVN.S) CHF83.10 +0.20
Merck & Co., Inc. (MRK.N) $65.79 -0.16
Roche Holding Ltd. (ROG.S) CHF248.60 +1.60
Roche Holding Ltd. (RO.S) CHF249.10 +1.50
Abbott Laboratories (ABT.N) $51.89 +0.48
AstraZeneca plc (AZN.L) 4,790.00 +38.00
GlaxoSmithKline plc (GSK.L) 1,461.83 +7.83
Bristol-Myers Squibb Co (BMY.N) $63.49 +0.56

Earnings vs. Estimates